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Our understanding of brown adipose tissue (BAT) function in humans has increased
rapidly over the past 10 years. This is predominantly due to the development of powerful
non-invasive imaging techniques such as positron emission tomography that can quantify
BAT mass and function using metabolic tracers. Activation of BAT during cold–induced
thermogenesis is an effective way to dissipate energy to generate heat and requires
utilization of multiple energy substrates for optimal function. This has led to interest in the
activation of BAT as a potential therapeutic target for type 2 diabetes, dyslipidaemia, and
obesity. Here, we provide an overview of the current understanding of BAT substrate
utilization in humans and highlight additional mechanisms found in rodents, where BAT
more prominently contributes to energy expenditure. During thermogenesis, BAT
demonstrates substantially increased glucose uptake which appears to be critical for
BAT function. However, glucose is not fully oxidized, with a large proportion converted to
lactate. The primary energy substrate for thermogenesis is fatty acids, released from
brown adipocyte triglyceride stores. Active BAT also sequesters circulating lipids to
sustain optimal thermogenesis. Recent evidence reveals that metabolic intermediates
from the tricarboxylic acid cycle and glycolytic pathways also play a critical role in BAT
function. Understanding the role of these metabolites in regulating thermogenesis and
whole body substrate utilization may elucidate novel strategies for therapeutic
BAT activation.
Keywords: brown adipose tissue, metabolism, thermogenesis, substrate, obesity, positron emission tomography
(PET), lipids, glucoseINTRODUCTION
The incidence of obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease has increased
globally over the last 50 years and interventions to curb obesity have been unsuccessful (1). The
majority of pharmacological approaches to treat obesity target caloric intake or absorption (2) with
substantially less effort targeting the other side of the energy balance equation, energy expenditure.
Brown adipose tissue (BAT), a thermogenic organ with substantially higher mitochondrial content
than white adipose tissue (WAT) (3) that causes its brown appearance, presents a uniquen.org September 2020 | Volume 11 | Article 5716591
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increases energy expenditure through oxidation of energy
substrates (4).
While well characterised in rodents, until recently BAT was
thought only to be found in human infants, however BAT has
been identified in the supraclavicular, axillary, and paraspinal
regions of adult humans and retains its thermogenic function
(5). BAT is stimulated by cold exposure which induces
sympathetic activation of b3-adrenergic receptors [b3AR, and
possibly b1AR and b2AR (6, 7)] which activates the inner
mitochondrial membrane (IMM) transporter uncoupling
protein 1 (UCP1) (8, 9). UCP1 transports protons generated
from the electron transport chain across the IMM in a process
uncoupled from ATP synthesis, generating heat for non-
shivering thermogenesis (10). Thermogenesis is an energy
intensive process, therefore BAT has a high metabolic
demand. A variety of metabolic substrates are utilized by, and
are critical for, BAT to initiate and maintain thermogenesis
including intracellular triglycerides, circulating free fatty acids
(FFA) and glucose. Uptake and utilization of these substrates
can improve metabolic health (11).
Recent work has highlighted that BAT thermogenesis utilizes
a more complex substrate range than merely glucose and fattyFrontiers in Endocrinology | www.frontiersin.org 2acids (12, 13). This complexity raises important questions
regarding the mechanisms regulating BAT activation. In order
to target BAT therapeutically, it is essential to understand the key
pathways involved in thermogenesis. In this mini-review, we will
discuss our understanding of the role and importance of
substrate utilization by human BAT and highlight the key
remaining questions.THE ROLE OF GLUCOSE UPTAKE BY BAT
To date, 18Fluorodeoxyglucose (18FDG)-PET/CT is the most
widely used technique to quantify BAT mass and activity in
humans by measuring glucose uptake in active BAT (14). This
technique has identified multiple BAT depots including the
supraclavicular and paracervical regions in adults and revealed
that total BAT mass varies widely between subjects from ~10–
300 grams (5, 15–17). However, this may be an underestimate
as only active depots with significant glucose uptake are
detected by this method. Glucose uptake by BAT during
warm/thermoneutral conditions ranges from ~10 nmol/g/
min using 18FDG-PET (5, 18, 19) up to ~50 nmol/g/min
using microdialysis (12). Both techniques demonstrateTABLE 1 | Quantification of substrate utilization by human BAT.
Substrate Lean/overweight
adults during warm
(nmol/g/min)
Lean/overweight adults during cold (nmol/g/min) Overweight/obese
adults during warm
(nmol/g/min)
Overweight/obese
adults during cold
(nmol/g/min)
Adults with T2DM
during cold
(nmol/g/min)
Glucose
uptake
50 (12) – 3h at 24-25°C,
microdialysis
10 (20) – duration/temp
not specified
10 (5) – 2h, temp not
specified
10 (21) – duration/temp
not specified
Acute cold exposure studies
110 (18) – 3h at 18°C using water cooled suit
55 (22) – 2h at 18°C using water cooled suit
70 (20) – 2h at 17°C
120 (5) – 2h at 17-19°C
90 (21) – 2h at 17°C
70 (23) – 3h at 18°C using water cooled suit
170 (19) – 2h at 18°C using water cooled suit
160 (12) – 3h at 17°C, microdialysis
69 (15) – ½h, individualised cooling protocol using
water cooled suit
45 (24) – 4h at 18°C using water cooled suit
Mean uptake from all studies: 96
Cold acclimation studies
170➔210 (19) – before/after using water cooled suit
at 10°C for 2h/day for 5 days a week for 4 weeks
69➔76 (15) – before/after 15-16°C for 2-6h/day for
10 days
45➔50 (24) – before/after individualised cooling
protocol using water cooled suit for 2h/day for 5
days a week for 4 weeks
11 (20) – 2h at 23°C 35 (20) – 2h at 17°C 15 (18) – 3h at 18°C
using water cooled
suit
FFA
uptake
8 (25) – 22°C, duration
not specified
6.5 (26) – 22°C,
duration not specified
12 (18) – 3h at 18°C using water cooled suit
13 (22) – 2h at 18°C using water cooled suit
13 (25) – 2h at 6°C using water cooled blanket
12 (26) – 2h at 6°C using water cooled blanket
12 (18) – 3h at 18°C
using water cooled
suit
Dietary FA
uptake
3 (24) – >2hrs at 18°C using water cooled suit
Glutamate
uptake
25 (12) – 3h at 24-25°C,
microdialysis
35 (12) – 3h at 17°C, microdialysisSeptember 2020 | VolumeData are approximate mean or median values from the various reported studies to quantify substrate utilization by BAT. The data presented were all obtained using dynamic PET/CT apart
from Weir et al. (12) that used microdialysis. The times in hours indicate the duration of warm/cold exposure prior to scanning, or total exposure for (12). Unless otherwise stated, the
temperatures indicate the ambient temperature of the room in which the volunteers were housed.11 | Article 571659
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nmol/g/min in young healthy subjects (5, 12, 18, 19) (Table 1),
in-keeping with an important role for glucose during
thermogenesis. During cold exposure, glucose uptake by
BAT is greater than skeletal muscle per gram of tissue but
due to the low mass in adults BAT accounts for <1% of total
body glucose uptake during thermogenesis, compared with
~50% by skeletal muscle (23). Repeated cold exposure can
further increase glucose uptake by BAT (Table 1) and increase
BAT oxidative metabolism and cold-induced thermogenesis
(15, 19). This may be due to increased BAT mass or activation
of previously dormant BAT (27, 28). Glucose uptake by BAT
correlates with cold-induced thermogenesis in healthy
humans, consistent with an important role for glucose
during BAT thermogenesis (12, 15). However, this is not
observed in al l studies and comparisons are often
confounded by substantial differences in cooling protocols
between studies (Table 1) and the often unmeasured
contribution of skeletal muscle shivering which accounts for
the majority of cold-induced thermogenesis (25, 29).
Early studies using static PET scanning demonstrated
decreased 18FDG uptake by BAT in those with increasing age,
weight and fasting glucose, suggesting dysregulation of BAT
activity in metabolic disease (28, 30–32). Dynamic PET studies
have subsequently quantified the reduction in cold-induced
glucose uptake by BAT in obesity and diabetes (Table 1).
Interestingly, whilst 18FDG glucose uptake is reduced in
T2DM and age-matched controls compared to a healthy
young group (mean age 59 vs 24 years), FFA uptake and BAT
oxidative metabolism (measured by 11C-acetate) were similar
between groups (18). These data indicate that reduced glucose
uptake by BAT may not accurately reflect BAT thermogenesis
at least in older or diabetic subjects. For example, reduced
glucose uptake could be caused by increased insulin resistance
without necessarily reducing BAT thermogenesis, potentially
calling into question the importance of BAT glucose
metabolism (18).
However, other evidence suggests glucose is important for
optimal BAT function. The glucose transporters GLUT1 and
GLUT4 are expressed in human BAT and are responsible for
glucose uptake into brown adipocytes, where it undergoes
glycolysis (21, 33). GLUT4 but not GLUT1 expression
substantially increases during human brown adipocyte
differentiation, while inhibition of GLUT4 reduces glucose
uptake and thermogenesis, suggesting GLUT4 is the more
important transporter in human BAT (34). In addition,
glucocorticoids increase 18FDG uptake by human BAT in vivo
and acutely increase GLUT4 but not GLUT1 mRNA levels in
primary human brown adipocytes (33), while prolonged cold
exposure increased GLUT4 expression and glucose uptake by
BAT in vivo in rats (35). In mice, either shRNA knockdown of
GLUT1 in interscapular BAT or inhibition of glycolysis via the
injection of 2-deoxy-D-glucose inhibited in vivo optogenetic
stimulation of sympathetic nerve activation of non-shivering
thermogenesis (36). Finally, suppression of BAT thermogenesisFrontiers in Endocrinology | www.frontiersin.org 3by inhibiting lipolysis also substantially decreases glucose uptake
by BAT (23). Overall these data suggest glucose uptake and
utilization is important for optimal BAT function, although
further work is required to determine the specific role of
glucose at thermoneutrality and during thermogenesis in
health and disease.
Glucose Utilization by BAT
The fate of glucose during thermogenesis and thermoneutral
conditions is an area of great interest and uncertainty in human
BAT. Glucose intermediates, generated via the glycolytic
pathway, are likely integral to BAT function (Figure 1).
Pyruvate, the product of glycolysis, can be converted to acetyl
coenzyme A (acetyl-CoA) by pyruvate dehydrogenase (PDH) to
feed into the tricarboxylic acid (TCA) cycle. The mitochondrial
pyruvate transporters MPC1 and MPC2 are highly expressed in
rodent BAT and upregulated by cold exposure (37, 38).
Furthermore, we found higher expression of the PDH subunit
PDHA1 (and a trend for PDHB) in human BAT compared with
WAT, in-keeping with conversion of pyruvate to acetyl-CoA in
human BAT (12). Acute b3AR stimulation also increases PDH
activity in immortalised murine brown adipocytes (39). While
acetyl-CoA may drive oxidative phosphorylation in the TCA
cycle to meet increased respiratory demands (39), citrate formed
during this process can also be used for de novo fatty acid (FA)
synthesis (Figure 1) (37). FAs formed via this pathway are not
directly used as fuel for UCP1-mediated thermogenesis but
instead are used to replenish intracellular triglyceride stores to
provide FAs during thermogenesis (40).
Glucose may also contribute to the replenishment of triglyceride
stores in BAT through conversion of glyceraldehyde-3-phosphate,
one of the intermediates in the glycolytic pathway, to glycerol-3-
phosphate which subsequently forms the glycerol backbone during
triglyceride synthesis (Figure 1). 13C-glucose tracing in B3AR-
stimulated immortalised murine brown adipocytes revealed that a
proportion of glycerol in triglycerides is derived from this process,
although most of the glucose was oxidized by these cells (39). BAT
expresses pyruvate carboxylase and it is also possible that glucose is
converted to oxaloacetate for anaplerosis (41). The contribution of
glucose metabolism to these processes in human BAT is currently
unknown and requires further investigation. However, we recently
identified that conversion of pyruvate to lactate is an important
pathway in human BAT (12).
In healthy subjects, lactate release by BAT is ~4-fold
greater than WAT and accounts for the majority of glucose
uptake at thermoneutrality and >50% during cold activation
(12). Similarly, noradrenaline stimulation induces substantial
lactate release from rat BAT (42). The lactate transporters
monocarboxylate transporter 1 and 4 (MCT1/4) are highly
expressed in rodent BAT whilst MCT1 expression is increased
by cold exposure or by activation of the sympathetic nerves
innervating BAT (36, 43). Pharmacological inhibition of MCT1
(expressed on plasma and mitochondrial membranes) or lactate
dehydrogenase (LDH) reduces BAT thermogenesis (36). These
data highlight the importance of lactate within BAT, althoughSeptember 2020 | Volume 11 | Article 571659
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Although the majority of lactate is exported from the cell, a
proportion may directly feed into the TCA cycle (44) or be
converted to fatty acids (45) (Figure 1). The high rates of lactate
production in active BAT may also be critical to maintain
optimal cellular redox balance during thermogenesis (46, 47).
Further, human BAT has high expression of the lactate receptor
GPR81 which inhibits lipolysis when activated (12, 48). The high
lactate levels in human BAT observed during thermoneutrality
may inhibit lipolysis though GPR81 to maximise triglyceride
storage for subsequent cold-induced BAT activation (12).
Further research is required to investigate the role of lactate in
human BAT.
The mechanistic insights into the role of glucose in BAT are
predominantly derived from rodent studies and it will be
important to confirm these in humans. Understanding the
specific roles of glucose metabolism during thermogenesis may
identify novel pathways for therapeutic manipulation to activate
BAT which may have important implications for improving
glucose homeostasis in metabolic disease (49).Frontiers in Endocrinology | www.frontiersin.org 4USE OF INTRACELLULAR TRIGLYCERIDES
Whilst the fate of glucose is still being elucidated, the role of
intracellular triglycerides in BAT is more clearly understood. In
rodents, FAs hydrolysed from intracellular triglyceride stores are
the primary substrate for thermogenesis (50, 51). Inhibition of
lipolysis in vivo and in vitro substantially inhibits rodent BAT
activity (50, 51). Similarly in humans, BAT activation depletes
intracellular triglyceride stores, as demonstrated either by the
increased radio-density of BAT observed when using CT
scanning during cold exposure (19, 22) or by a reduced fat
fraction when using MRI (52, 53). Older people, irrespective of
T2DM status, have a higher fat fraction in BAT compared with
young controls at room temperature and during cold exposure
(18). In addition, an increased BAT fat fraction is associated with
increased insulin resistance, consistent with a role for BAT activity
in metabolic disease (54). However, fat fraction is not substantially
reduced in those with greater BAT activity and fat fraction can
decrease during cold activation even in subjects without detectable
18FDG uptake by BAT (18, 52, 53). One possible reason why fatFIGURE 1 | Diagram of substrate utilization and suspected pathways in BAT. Glucose enters the brown adipocyte via GLUT4 and GLUT1 where it undergoes
glycolysis to form pyruvate. Pyruvate is converted to lactate and exported from the cell by the monocarboxylate (MCT) transporters, this pathway accounts for the
majority of glucose uptake by human BAT during both warm and cold exposure. Following export, lactate may activate GPR81 which inhibits lipolysis. Alternatively,
pyruvate can enter the mitochondria and be incorporated into the TCA cycle following conversion to acetyl-CoA. Citrate, one of the TCA cycle intermediates, may
also be converted to acetyl-CoA in the cytosol as the first step of de novo lipogenesis (DNL). A proportion of glucose may be converted to glycerol-3-phosphate
(Glycerol-3-P), generated from glyceraldehyde-3-phosphate during glycolysis, to form the backbone for replenishment of intracellular triglycerides (TRGs). Free fatty
acids (FFAs) hydrolysed from local TRGs are the primary energy substrate used for uncoupled respiration during thermogenesis, which is mediated by mitochondrial
UCP1. Glycerol released by this process can either be exported or recycled through conversion to Glycerol-3-P by glycerol kinase (GK) for subsequent TRG
synthesis. In addition to DNL, uptake of circulating FFAs either directly or following lipoprotein lipase (LPL)-mediated hydrolysis of triglyceride rich lipoproteins (TRLs)
occurs via the fatty acid transporters or potentially by passive diffusion. BAT utilizes other circulating substrates during thermogenesis such as BCAAs, succinate and
glutamate which are all likely incorporated into the TCA cycle. Arrows in black indicate substrate transport/movement. Arrows in red represent enzymatic conversion.
Wording in black indicate pathway confirmed both in human and rodent BAT. Wording in blue indicate pathways confirmed in rodent BAT. Some reactions have
been simplified/omitted for brevity. ACC, acetyl-CoA carboxylase; ACL, ATP citrate lyase; AGPAT2, 1-acyl-sn-glycerol-3-phosphate acyltransferase beta; AQP7,
aquaporin-7; ATGL, adipose triglyceride lipase; CD36, fatty acid translocase; CoQ, coenzyme Q; DGAT2, diacylglycerol acyltransferase 2; FABP, fatty acid binding
protein; FASN, fatty acid synthase; FATP, fatty acid transport protein; GPAT3, glycerol-3-phosphate acyltransferase 3; GPR81, G-protein coupled receptor 81; HSL,
hormone sensitive lipase; LDH, lactate dehydrogenase; MPC1/2, mitochondrial pyruvate carrier 1 and 2; PDH, pyruvate dehydrogenase; SLC13A3, solute carrier
family 13 member 3; SLC25A10, solute carrier family 25 member 10; SLC25A44, solute carrier family 25 member 44.September 2020 | Volume 11 | Article 571659
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is the heterogeneous nature of BAT, as human BAT contains
regions with higher and lower lipid content (55). In addition, the
fat fraction of distinct areas within BAT can increase during
thermogenesis, highlighting the importance of triglyceride
regeneration to maintain energy stores (55).
Recent evidence in humans strongly suggest that intracellular
triglycerides are the primary fuel source for non-shivering
thermogenesis as in rodents (Figure 1), as inhibition of
lipolysis reduces BAT thermogenesis and the change in BAT
radio-density during cold exposure (23). Furthermore,
quantification of BAT lipolysis was undertaken by measuring
glycerol release from BAT using microdialysis in healthy lean
men, this was substantially increased during cold exposure (12).
FFA release during BAT activation was estimated to be ~65
nmol/g/min which would account for the majority of BAT
thermogenesis (12). While export of glycerol occurs most likely
via the aquaporin 7 glycerol transporter (56, 57), the enzyme
glycerol kinase is highly expressed in rodent (50) and human
BAT (12, 58), which converts glycerol to glycerol-3-phosphate
for subsequent replenishment of triglyceride stores. This strongly
suggests that not all glycerol is released so this estimate of local
lipolysis by BAT may be a significant underestimate. In addition,
glycerol kinase expression is substantially increased by cold
exposure in rats (50), highlighting the importance of this
pathway during thermogenesis.FATTY ACID UPTAKE BY BAT
Although BAT lipid content acutely decreases following cold
activation this does not further change during prolonged cold
exposure, suggesting that intracellular triglycerides are
constantly replenished (Figure 1) (22, 59). As discussed above,
glucose may contribute to this either through glyceroneogenesis
and/or de novo lipogenesis. Circulating triglyceride rich
lipoproteins (TRLs) and FFAs are also key sources of FAs for
this process. Cold exposure increases whole body lipolysis, which
enhances circulating fatty acid substrate availability (11, 12). Use
of the FA PET tracer 18fluoro-6-thia-heptadecanoic acid
(18FTHA) confirmed uptake of FFAs by BAT during cold
exposure (22). FA uptake by BAT during both warm and cold
exposure correlates with BAT thermogenesis, in-keeping with an
important role for FA uptake in BAT function (25). FFA uptake
rates by BAT during cold exposure are ~12.5 nmol/g/min (22)
and potentially unchanged in older or diabetic subjects (Table 1)
(18). FFA uptake by BAT only accounted for ~0.25% of plasma
FFA turnover, suggesting that BAT may not have an important
role in systemic FFA clearance. FFA uptake by BAT is mediated
by several transporters including fatty acid binding protein, fatty
acid transport protein, and CD36 (Figure 1) (60–62). CD36 also
plays an important role in Coenzyme Q uptake and fatty acid
oxidation (63). However, the fate of these FFAs following uptake
by BAT is currently unclear and other fatty acid tracers are
required to determine whether FAs taken up by BAT are
oxidized or incorporated into triglyceride stores.Frontiers in Endocrinology | www.frontiersin.org 5Uptake of FAs from circulating TRLs occurs through the
action of lipoprotein lipase (LPL) (64). LPL-mediated TRL
uptake by BAT can account for ~50% of systemic TRL
clearance in rodents during cold exposure (61, 65, 66). In
addition, LPL expression is increased in human BAT but not
WAT following cold exposure, highlighting a potentially
important role in triglyceride clearance (11). While human in
vivo data are limited, these suggest this mechanism is present in
human BAT. There was detectable uptake of the fatty acid tracer
18FTHA by BAT, given orally as part of a lipid meal during cold
exposure, confirming that BAT sequesters dietary FAs in
humans (24). However, 18FTHA by BAT uptake was not
increased following a 4-week cold acclimation protocol despite
substantially increasing BAT activity. BATs contribution to total
dietary fatty acid clearance was estimated to be ~0.3%, although
the 18FTHA uptake by BAT was proportionately higher per gram
of tissue than skeletal muscle or WAT (24). The difference in
systemic clearance between species may be due to the lower
proportional BAT mass in humans. Prolonged BAT activation
using the b3AR agonist mirabegron for 4 weeks in humans
increases HDL-C concentrations, potentially as a result of
enhanced TRL clearance (49). However, the specific role of
BAT in this process is unclear and further research is required
to quantify the contribution of human BAT to triglyceride
clearance during thermoneutral and cold conditions and
whether these FAs are immediately oxidized or used to
replenish triglyceride stores. Nevertheless, chronic activation of
BAT in humans may induce a more favourable lipid profile
which may reduce cardiovascular risk.UTILIZATION OF ADDITIONAL
SUBSTRATES BY BAT
While glucose, internal triglyceride stores and FFA are clearly
defined as substrates with key roles in BAT thermogenesis, there
is emerging evidence that other substrates contribute to BAT
function. Using the microdialysis technique, we discovered
substantial glutamate uptake by BAT in vivo which was
increased during cold exposure [∼35 nmol/g/min in the
cold vs ∼25 nmol/g/min in warm conditions (Table 1)
(12)]. Cold exposure did not increase glutamate uptake by
WAT, highlighting a specific role for the amino acid during
thermogenesis. The function of glutamate in BAT is unclear and
requires further study, however glutamate dehydrogenase is
expressed in human BAT which converts glutamate to a-
ketoglutarate (12), suggesting the glutamate may be oxidized or
contributes to anaplerosis. However, glutamate uptake is
considerably lower than glucose, indicating this is unlikely to
be a major substrate for thermogenesis. In addition, enhanced
utilization and depletion of intracellular glutamate may increase
glucose uptake by BAT, as glutamate inhibits glucose uptake in
white adipocytes (67).
Branched chain amino acids (BCAAs) also contribute to BAT
non-shivering thermogenesis. In humans, cold exposure
enhances systemic clearance of the BCAAs valine and leucineSeptember 2020 | Volume 11 | Article 571659
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expression of the mitochondrial transporter SLC25A44 (which
can transport valine and leucine) was higher in human BAT
following cold exposure. Highlighting a potential thermogenic
role, these BCAAs can be incorporated into TCA cycle
intermediates such as succinate, while valine enhanced
mitochondrial respiration in stimulated human brown
adipocytes in vitro (13). Finally, BAT-specific knockdown of
SLC25A4 in mice impaired thermogenesis, highlighting a crucial
role for BCAA uptake by BAT in vivo at least in mice (13).
However, the importance and contribution of these BCAAs to
human BAT thermogenesis in vivo is unclear at present.
Whether the reduced BAT activity associated with obesity
contributes to the elevated circulating BCAA levels seen in
these subjects (68) is also unknown.
Recent work also implicates the TCA cycle metabolite
succinate as a key regulator of BAT thermogenesis. In mice,
cold exposure induces sequestration of succinate from the
circulation and accumulation in BAT (69, 70). Noradrenaline
stimulation of human brown adipocytes in vitro also increases
intracellular succinate levels (13). Highlighting an important role
for this intermediate, succinate treatment increased oxygen
consumption in human and murine brown adipocytes in vitro
and in mice dietary supplementation of succinate enhanced BAT
thermogenesis in vivo, which is mediated through incorporation
of succinate into the TCA cycle (69). Interestingly and as noted
above with the BCAAs, circulating succinate levels are higher in
obese and diabetic subjects (71) which suggests that succinate
supplementation is unlikely to enhance BAT thermogenesis in
this group, although this is yet to be tested.Frontiers in Endocrinology | www.frontiersin.org 6CONCLUSION
Our knowledge of substrate utilization by human BAT has
improved over the past 10 years, thanks primarily to the use of
PET imaging and more recently the application of adipose tissue
microdialysis. However, a number of fundamental questions
remain such as the fate of glucose and how the triglyceride
pool is replenished. While local triglycerides are the primary
energy substrate in BAT thermogenesis, it is clear that a number
of other substrates play significant roles, although their specific
contributions and function remain to be elucidated. If BAT is to
be used as a novel therapy for metabolic disease a thorough
understanding of the pathways that contribute to BAT
thermogenesis is paramount, in addition to determining the
maximal metabolic capacity of this organ. In order to achieve
sustained improvements in glucose and lipid homeostasis
through BAT activation, these pathways may hold the key.AUTHOR CONTRIBUTIONS
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18. Blondin DP, Labbé SM, Noll C, Kunach M, Phoenix S, Guérin B, et al.
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